These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2292468)
1. Effect in vitro of a bacterial extract (OM-89) on interleukin 1 and interleukin 2 production by peripheral blood mononuclear cells from healthy subjects and rheumatoid arthritis patients. Clot J; Andary M Int J Immunopharmacol; 1990; 12(8):909-13. PubMed ID: 2292468 [TBL] [Abstract][Full Text] [Related]
2. Effects of a hydrosoluble bacterial extract from Escherichia coli (OM-89) on cytokine production by peripheral blood mononuclear cells from healthy subjects and patients with rheumatoid arthritis. Franchimont N; Vrindts-Gevaert Y; Collette J; Franchimont P Scand J Rheumatol; 1991; 20(3):196-203. PubMed ID: 2068542 [TBL] [Abstract][Full Text] [Related]
3. Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment. Seitz M; Zwicker M; Wider B J Rheumatol; 2001 Mar; 28(3):496-501. PubMed ID: 11296948 [TBL] [Abstract][Full Text] [Related]
4. Enhanced interleukin 1 generation by monocytes in vitro is temporally linked to an early event in the onset or exacerbation of rheumatoid arthritis. Shore A; Jaglal S; Keystone EC Clin Exp Immunol; 1986 Aug; 65(2):293-302. PubMed ID: 3491707 [TBL] [Abstract][Full Text] [Related]
5. Role of endogenous prostaglandin E2 in interleukin 1 production by peripheral blood monocytes from patients with rheumatoid arthritis. Yamamura M; Nishiya K; Ota Z Acta Med Okayama; 1990 Feb; 44(1):13-20. PubMed ID: 2330842 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of cytokine production and natural killer activity by an Escherichia coli extract. Wybran J; Libin M; Schandene L Onkologie; 1989 Jun; 12 Suppl 3():22-5. PubMed ID: 2514401 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 production by mononuclear cells from rheumatoid synovial effusions. Bhardwaj N; Lau LL; Rivelis M; Steinman RM Cell Immunol; 1988 Jul; 114(2):405-23. PubMed ID: 3260544 [TBL] [Abstract][Full Text] [Related]
8. Deficient interleukin 2 production in rheumatoid arthritis: association with active disease and systemic complications. Kitas GD; Salmon M; Farr M; Gaston JS; Bacon PA Clin Exp Immunol; 1988 Aug; 73(2):242-9. PubMed ID: 2972426 [TBL] [Abstract][Full Text] [Related]
9. Release of lymphokines after infection with Epstein Barr virus in vitro. II. A monocyte-dependent inhibitor of interleukin 1 downregulates the production of interleukin 2 and interferon-gamma in rheumatoid arthritis. Lotz M; Tsoukas CD; Fong S; Dinarello CA; Carson DA; Vaughan JH J Immunol; 1986 May; 136(10):3643-8. PubMed ID: 3009609 [TBL] [Abstract][Full Text] [Related]
10. Bacterial extract (OM-89) specific and non specific immunomodulation in rheumatoid arthritis patients. Toussirot E; Robinet E; Saas P; Chabod J; Augé B; Cozma G; Tiberghien P; Roudier J; Wendling D Autoimmunity; 2006 Jun; 39(4):299-306. PubMed ID: 16891218 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 and interleukin-2 production by peripheral blood mononuclear cells of patients with rheumatoid arthritis. Rozenbaum M; Scharf Y; Katz R; Pollack S Isr J Med Sci; 1989 Jul; 25(7):372-6. PubMed ID: 2788150 [TBL] [Abstract][Full Text] [Related]
12. Production of tumour necrosis factor-alpha, interferon-gamma and interleukin-2 by peripheral blood mononuclear cells of subjects suffering from rheumatoid arthritis. Franchimont P; Reuter A; Vrindts-Gevaert Y; Bastings M; Malaise M; Sondag C; Frere MC; Gysen P Scand J Rheumatol; 1988; 17(3):203-12. PubMed ID: 3140372 [TBL] [Abstract][Full Text] [Related]
13. Radio-immunological study of the regulation of interleukin-2 production in peripheral blood mononuclear cell cultures from normal subjects and rheumatoid arthritis patients. Bernier J; Reuter A; Vrindts-Gevaert Y; Gathy-Meuleman R; Frere MC; Franchimont P Clin Exp Rheumatol; 1989; 7(1):35-41. PubMed ID: 2785012 [TBL] [Abstract][Full Text] [Related]
14. Antiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain reaction. Constantin A; Loubet-Lescoulié P; Lambert N; Yassine-Diab B; Abbal M; Mazières B; de Préval C; Cantagrel A Arthritis Rheum; 1998 Jan; 41(1):48-57. PubMed ID: 9433869 [TBL] [Abstract][Full Text] [Related]
15. Immuno-enhancing effects of ricin. Krakauer T Immunopharmacol Immunotoxicol; 1991; 13(3):357-66. PubMed ID: 1940053 [TBL] [Abstract][Full Text] [Related]
16. Regulation of interleukin-18 binding protein production by blood and synovial cells from patients with rheumatoid arthritis. Kawashima M; Novick D; Rubinstein M; Miossec P Arthritis Rheum; 2004 Jun; 50(6):1800-5. PubMed ID: 15188356 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-2 inhibitor in rheumatoid arthritis synovial fluid does not inhibit mononuclear cell responses to mitogens. Hollander AP; Elson CJ Autoimmunity; 1990; 5(4):237-45. PubMed ID: 2129757 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 production and effect of thymosin fraction 5 on interleukin-2 production in rheumatoid arthritis. Wolf RE; Hall VC J Rheumatol; 1987 Oct; 14(5):898-901. PubMed ID: 3123674 [TBL] [Abstract][Full Text] [Related]
20. Increased production of IL-6 and IL-17 in lipopolysaccharide-stimulated peripheral mononuclears from patients with rheumatoid arthritis. Chovanova L; Vlcek M; Krskova K; Penesova A; Radikova Z; Rovensky J; Cholujova D; Sedlak J; Imrich R Gen Physiol Biophys; 2013 Sep; 32(3):395-404. PubMed ID: 23817641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]